Viewing Study NCT05174650


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-29 @ 1:30 AM
Study NCT ID: NCT05174650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2021-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module